PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Aug-2022 Hemostatic Gels Market to Grow at a 6.8% CAGR through 2032 MARKITWIRED
29-Aug-2022 HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022 MARKITWIRED
29-Aug-2022 Uni-Bio Science Group Limited: 2022 Interim Results UNI-BIO SCIENCE GROUP LIMITED
29-Aug-2022 Latest simulation analyses from the SANTORINI registry indicates that adding bempedoic acid in the lipid lowering treatment algorithm might help more patients achieve LDL-C recommended goals Daiichi Sankyo Europe
29-Aug-2022 New data further strengthens important role of LIXIANA® (edoxaban) in managing complex patient populations with atrial fibrillation (AF) Daiichi Sankyo Europe
29-Aug-2022 Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214 Moderna, Inc.
29-Aug-2022 Neuroendocrine Carcinoma Market Size, Top Leading Manufacturers with Share 2029 MARKITWIRED
29-Aug-2022 Human Identification Market Opportunities and Challenges, Growth by 2029 MARKITWIRED
29-Aug-2022 Continuous Renal Replacement Therapy Market Comprehensive Study Explores Huge Growth In Future MARKITWIRED
29-Aug-2022 Teleradiology Market Analysis, Size, Applications Share, Trends & Forecast To 2032 MARKITWIRED
29-Aug-2022 Orthopaedic Bone Cement and Casting Materials Market Future Demands, Regional Developments and Industry Competitive Landscape Analysis MARKITWIRED
29-Aug-2022 Dental Burs Market Size to Exceed US$ 295.6 Million by 2032 MARKITWIRED
29-Aug-2022 Dental X-ray Systems Market Size to Hit USD 2.73 Billion by 2030 MARKITWIRED
29-Aug-2022 European Commission approves FYB201/Ranivisio®1 (Ranivisio - Ranibizumab), a biosimilar to Lucentis®2 (news with additional features) Formycon AG
29-Aug-2022 European Commission Approves FYB201/Ranivisio®(1) (Ranivisio - Ranibizumab), a Biosimilar to Lucentis®(2) B3C newswire
29-Aug-2022 BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting BRAIN Biotech AG
29-Aug-2022 Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients Kinarus Therapeutics Holding AG
29-Aug-2022 Refractive Surgery Devices Market Predicted to Reach a Valuation of US$ 332.6 Billion by The End of 2032 MARKITWIRED
29-Aug-2022 Suture Needles Market Share Demand in Conservative Scenario with Product Life Cycle Analysis & Demand in Likely Scenario-2032 MARKITWIRED
29-Aug-2022 Patient Identification Wristbands Market is set to experience a significant growth of 7.9% CAGR from 2022 to 2030 MARKITWIRED